Clinical Trial Update: Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia [Phase 1]

View source ↗

Summary

A Phase 1b clinical trial evaluating VERVE-201 for patients with refractory hyperlipidemia is currently recruiting to assess safety and pharmacology.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• VERVE-201

Snippet

Sponsor: Verve Therapeutics, Inc. | Conditions: Hypercholesterolemia, Hypertriglyceridemia | Phase 1 | Status: RECRUITING